Claims for Patent: 9,353,088

Summary for Patent: 9,353,088

Title:	Crystalline pharmaceutical and methods of preparation and use thereof
Abstract:	Novel crystalline polymorphic forms, Forms A, B, C, D, and E of a compound of Formula I, which has been found to be a potent inhibitor of LFA-1, are disclosed. Methods of preparation and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed in this invention. ##STR00001##
Inventor(s):	Burnier; John (Pacifica, CA)
Assignee:	SARcode Bioscience Inc. (Brisbane, CA)
Application Number:	14/556,715
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 9,353,088
Patent Claims:	1. A composition comprising an isolated compound of Formula I: ##STR00020## wherein said compound is synthesized according to a method comprising the steps: performing hydrolysis of Formula AA with a base: ##STR00021## wherein R is a carbon containing moiety: and isolating the compound of Formula I, wherein said composition is essentially free of a chemical catalyst. 2. The composition of claim 1, wherein R is a substituted or unsubstituted group selected from lower alkyl, lower alkenyl, lower alkynyl, cyclo(lower)alkyl, cyclo(lower)alkenyl, aryl, aralkyl, heterocyclyl, and heteroaryl groups. 3. The composition of claim 1, wherein R is benzyl. 4. The composition of claim 1, wherein the base is sodium hydroxide.